[PubMed: 8786016] (Among 328 patients with diabetic peripheral neuropathy treated with ALA [100, 600, or 1200 mg] or placebo intravenously 4 to 5 days per week for 3 weeks, total neuropathy symptom scores improved by 43%, 63% and 58% with ALA vs 38% with placebo, while adverse events were similar with the lower doses as with placebo [14% and 18% vs 21%] but higher with the highest dose [33%]
We do not accept Medicare or Medicaid, including Medicare Advantage and Medicaid managed care plans
Semaglutide Before and After Results Looking at Semaglutide progress pictures , youll see dramatic transformations
We offer Semaglutide GLP-1 , a medication known for its effectiveness in controlling high blood sugar levels and aiding weight loss
Product Highlights Targets Dark Spots & Hyperpigmentation: Effectively diminishes discoloration for a clearer complexion
Learn more about why working with a naturopath can make the difference between spinning your wheels and actually getting somewhere